Dr Chris Reilly
Chris is a scientist and business leader with over 30 years’ experience in medical research, life science consultancy and venture capital in the UK, USA and Sweden. He began
his career as a research scientist and retired in 2011 as Global Vice President, Discovery Strategy, Performance and Project Evaluation at AstraZeneca, a large international pharmaceutical company. In this role, Chris was responsible for developing AstraZeneca’s research strategy, business plan and performance improvement activities. He has considerable experience in managing and leading large complex organisations.
Chris also spent two years with a venture capital firm in Boston that invested in new life science companies. He currently provides a consultancy service focused on ‘translational medicine’ for medical charities, academic institutions, biotechnology companies and life science orientated government agencies. He has a Ph.D. in Biochemistry from the University of Georgia and performed his postdoctoral work at the Massachusetts Institute of Technology. He moved from the USA to Cheshire in 1993 and is married with